including obesity and both asthma and diabetes. The association between type 2 diabetes and asthma is not surprising as a high proportion of youth were overweight or obese (90.6%) and the linkage between asthma and increased BMI is well described in many studies. It is interesting to note that children whose asthma was treated with leukotriene modifiers, alone or in combination with inhaled corticosteroids or rescue inhalers, had the lowest prevalence of poor glycemic control; in fact, 72% had good glycemic control. The authors speculate that this could be because leukotriene synthesis or receptor blockers may help reduce the systemic inflammation present in both obesity and diabetes as well the direct effect on ameliorating airway inflammation. STUDY POPULATION. There were 2 groups studied, both involved children enrolled from pregnancy cohorts. The first group (Menorca cohort) was 122 children with data available through age 6 years. The second group (Sabadell cohort) was 236 children with available DNA extracted from whole cord blood.
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METHODS. Children were assigned wheezing phenotypes at age 4 to 6 years based on validated questionnaires (never, transient, late-onset, or persistent wheezing). Prenatal exposure data were collected through questionnaire and by measuring for presence of a specific pollutant, dichlorodiphenyldichloroethylene, in cord blood.
RESULTS. DNA hypomethylation was associated with increased risk for persistent wheezing in both studies, although only 1 of the 2 was statistically significant (Menorca: odds ratio 1.13, 95% confidence interval 0.99-1.29, P 5 .077; Sabadell: odds ratio 1.16, 95% confidence interval 1.03-1.37, P 5 .017). Higher levels of dichlorodiphenyldichloroethylene were associated with hypomethylation of ALOX12 in the Menorca study (P 5 .033), but not the Sabadell study (P 5 .377 ). Level of methylation at ALOX12 was strongly influenced by polymorphisms in the gene.
CONCLUSIONS. DNA hypomethylation at ALOX12 was associated with a higher risk of persistent wheezing. This may be an epigenetic biomarker that predicts increased likelihood of persistent wheezing in childhood.
REVIEWER COMMENTS. This study adds to the knowledge that genes and the environment combine to influence asthma phenotype. In this case, ALOX12, a gene associated with airway inflammation, appears to exhibit variation in methylation, not based on genotype alone, but possibly on environmental factors, including prenatal pollutant exposure. Therefore, the degree of methylation at certain CpG sites on this gene may be an early biomarker that helps to predict wheezing phenotype. METHODS. Microarray-derived genotypes of Australian asthmatic subjects and controls underwent a genomewide association study to produce asthma candidate loci. Meta-analysis using unique adult Australian and previously published GABRIEL genotypes prioritized candidate novel genetic loci. The prioritized, novel genetic loci endured replication analysis via 4 individual cohorts and a combined meta-analysis. A genomic phenotype prediction model for asthma was produced and subsequently tested. Secondary analysis considered asthma and other immune disease associations.
RESULTS. Two novel loci were significantly associated with asthma risk. The interleukin-6 receptor (IL6R) loci on chromosome 1q21.3 associated more significantly (odds ratio [OR] 5 1.09, P 5 .0033) than the indeterminate loci (rs7130588) at chromosome 11q13.5 (OR 5 1.07, P 5 .328) in the replication cohorts. However, when considering all available data, 1q21.3 and 11q13.5 both demonstrated very significant asthma association (OR 5 1.09, P 5 2.3 3 10 28 and OR 5 1.09, P 5 1.8 3 10 28 , respectively). Secondary analyses of 11q13.5 revealed an association with atopy and no asthma risk association in nonatopic individuals. Genomic phenotypic predictive modeling significantly predicted asthma cases, but demonstrated poor discriminative ability. Finally, associations between asthma and other immune diseases were noted.
CONCLUSIONS. Two novel loci (1q21.3 and 11q13.5) significantly associate with asthma risk with the use of large genome-wide discovery and replication cohorts.
REVIEWER COMMENTS. In a "big data" world, sifting reality from statistical chaff presents a significant challenge. By the use of genome-wide association study on several independent cohorts, the researchers give weight to their novel candidate loci. Although not previously associated with asthma risk, IL6R's feasible mechanistic connection to asthma encourages further investigation. Without a known function and with only loose atopy and Crohn associations, the proposed 11q13.5 locus carries much less biological heft. Despite the inclusion of known, novel, and marginally statistically significant genetic variances, the study's phenotypic predictive models lack discrimination value, likely because of data imprecision, missing environmental covariates, and other unappreciated asthma risk variables. Even so, more refined phenotypic predictive modeling holds great promise in translating everexpanding data into improved patient care. METHODS. Mice were infected with lymphocytic choriomeningitis virus (LCMV), a single-stranded RNA virus, and a genome-wide cDNA expression analysis of total spleen tissue was performed and compared with the uninfected mouse. From a large panel of interleukins and inflammatory cytokines, interferon-g and interleukin (IL)-33 (along with its receptor ST2) were the most highly upregulated. Infection with LCMV, as well as a murine herpesvirus (MHV-68), was performed in wildtype mice, mice deficient in IL-33 (in IL-33 2/2 ), and mice in which IL-33 effects were blocked with a soluble decoy receptor (Il1-rl1-Fc). Proliferative responses of cytotoxic lymphocytes (CTLs) specific for LCMV were measured.
RESULTS. Levels of IL-33 peaked at 3 to 5 days after infection, mirroring levels of LCMV mRNA. To further assess a cohort of children examining the relationship between mold exposures at 1 and 7 years of age and asthma at age 7 years.
STUDY POPULATION. The sample included 176 children with at least 1 atopic parent followed from birth to age 7 years.
METHODS. Home assessments, inspections, and floor dust sampling were done at age 1 and 7 years. Clinical examinations were performed at 1, 2, 3, 4, and 7 years of age and included history and skin testing to aeroallergens. At 7 years of age, spirometry pre-and postbronchodilator were performed, and, if negative, a methacholine challenge was undertaken. Children were defined as asthmatic if they had asthma symptoms and objective confirmation
